WHWK vs XLV
Whitehawk Therapeutics, Inc. (WHWK) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
XLV does not have a complete income-statement cache yet.
WHWK currently screens at market cap $202.8M. XLV currently screens at market cap $0.
Not investment advice. Open the WHWK and XLV stock pages for the full models.
Not investment advice.